[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335092-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335092-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-of-mesenchymal-stemstromal-cells-in-head-and-neck-cancer-regulatory-mechanisms-of-tumorigenic-and-immune-activity-chemotherapy-resistance-and-therapeutic-benefits","Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer - Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits","","Head and neck cancer (HNC) is a heterogeneous malignancy arising from mucosal epithelium of the upper aerodigestive tract and gastrointestinal tract, with substantial morbidity and mortality worldwide. Mesenchymal/stem stromal cells (MSCs) in the tumor milieu regulate tumor initiation, development, and patient outcomes, and contribute to resistance to cisplatin-based chemotherapy, the standard for advanced HNC. MSCs are multipotent, heterogeneous, and identifiable via markers such as CD73, CD90, and CD105, while lacking hematopoietic markers. In the tumor niche they can become quiescent, self-renewing, low in reactive oxygen species, and acquire epithelial-to-mesenchymal transition features that promote drug resistance and treatment failure. This narrative review connects MSC biology with HNC progression and resistance mechanisms in current chemo-radiotherapies, and discusses pharmacological targeting strategies to overcome stemness-related chemoresistance and enable more personalized therapeutic approaches.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-mesenchymal-stemstromal-cells-in-head-and-neck-cancer-regulatory-mechanisms-of-tumorigenic-and-immune-activity-chemotherapy-resistance-and-therapeutic-benefits/335092/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-mesenchymal-stemstromal-cells-in-head-and-neck-cancer-regulatory-mechanisms-of-tumorigenic-and-immune-activity-chemotherapy-resistance-and-therapeutic-benefits/335092.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What roles do mesenchymal/stem stromal cells play in head and neck cancer?","Question",{"text":63,"@type":64},"MSCs in the tumor milieu modulate tumor initiation and development and influence patient outcomes. They also regulate immune activity within the tumor environment and contribute to treatment resistance, especially to cisplatin-based chemotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do MSCs contribute to chemotherapy resistance and treatment failure?",{"text":68,"@type":64},"Within the tumor niche, MSC populations can show quiescence, self-renewal capacity, low reactive oxygen species production, and epithelial-to-mesenchymal transition-like properties. These features support acquisition of drug resistance and lead to failure of chemo-radiotherapy.",{"name":70,"@type":61,"acceptedAnswer":71},"How can stemness-related chemoresistance be pharmacologically targeted?",{"text":72,"@type":64},"The review examines the mechanisms behind stemness-associated chemoresistance and discusses possibilities for pharmacological targeting. It also highlights new strategies aimed at optimizing chemoradiotherapy and supporting more personalized treatment approaches.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335092,1790122713,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":104,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","cells  \nReview  \nRole of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer—Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies  \nKatarzyna Starska-Kowarska 1,2  \nCitation: Starska-Kowarska, K. Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer—Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies. Cells 2024, 13, 1270. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cells13151270](10.3390/cells13151270)  \nAcademic Editor: Veronika Lukacs-Kornek  \nReceived: 8 June 2024  \nRevised: 11 July 2024  \nAccepted: 26 July 2024  \nPublished: 28 July 2024  \nCopyright: © 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Physiology, Pathophysiology and Clinical Immunology, Department of Clinical Physiology, Medical University of Lodz, Z˙ eligowskiego 7/9, 90-752 Lodz, Poland; [katarzyna.starska@umed.lodz.pl](katarzyna.starska@umed.lodz.pl); Tel.: +48-42-2725237  \n2 Department of Otorhinolaryngology, EnelMed Center Expert, Lodz, Drewnowska 58, 91-001 Lodz, Poland  \nAbstract: Head and neck cancer (HNC) entails a heterogenous neoplastic disease that arises from the mucosal epithelium of the upper respiratory system and the gastrointestinal tract. It is characterized by high morbidity and mortality, being the eighth most common cancer worldwide. It is believed that the mesenchymal/stem stromal cells (MSCs) present in the tumour milieu play a key role in the modulation of tumour initiation, development and patient outcomes; they also influence the resistance to cisplatin-based chemotherapy, the gold standard for advanced HNC. MSCs are multipotent, heterogeneous and mobile cells. Although no MSC-specific markers exist, they can be recognized based on several others, such as CD73, CD90 and CD105, while lacking the presence of CD45, CD34, CD14 or CD11b, CD79α, or CD19 and HLA-DR antigens; they share phenotypic similarity with stromal cells and their capacity to differentiate into other cell types. In the tumour niche, MSC populations are characterized by cell quiescence, self-renewal capacity, low reactive oxygen species production and the acquisition of epithelial-to-mesenchymal transition properties. They may play a key role in the process of acquiring drug resistance and thus in treatment failure. The present narrative review examines the links between MSCs and HNC, as well as the different mechanisms involved in the development of resistance to current chemo-radiotherapies in HNC. It also examines the possibilities of pharmacological targeting of stemness-related chemoresistance in HNSCC. It describes promising new strategies to optimize chemoradiotherapy, with the potential to personalize patient treatment approaches, and highlights future therapeutic perspectives in HNC.  \nKeywords: anti-cancer therapy; carcinogenesis; cell plasticity; chemoresistance; head and neck cancer (HNC); head and neck squamous cell carcinoma (HNSCC); mesenchymal stromal cells (MSCs); tumour niche; tumour environment  \n1. Introduction  \nHead and neck cancer (HNC) comprises a heterogeneous group of malignant neoplasms developing from the mucosa of the oral cavity, pharynx, larynx, nose, salivary glands and oesophagus, with the former three being the most frequent [1,2] . More than 90% of HNCs are squamous cell carcinomas (HNSCCs) that originate from the mucosa of the oral cavity, oropharynx and larynx. All HNSCCs demonstrate morphological and molecular heterogeneity and thus also vary with regard to their clinical course [3] .","cbCaiaTKg1axxGzx","https://ap.wps.com/l/cbCaiaTKg1axxGzx","pdf",1985575,"English","# Introduction\n## Epidemiology of HNC\n# MSCs in the tumor microenvironment\n## Tumorigenic and immune activity regulation\n## Mechanisms of chemotherapy resistance\n# Therapeutic targeting strategies\n## Pharmacological benefits of stromal-cell-based approaches","[{\"question\":\"What roles do mesenchymal/stem stromal cells play in head and neck cancer?\",\"answer\":\"MSCs in the tumor milieu modulate tumor initiation and development and influence patient outcomes. They also regulate immune activity within the tumor environment and contribute to treatment resistance, especially to cisplatin-based chemotherapy.\"},{\"question\":\"How do MSCs contribute to chemotherapy resistance and treatment failure?\",\"answer\":\"Within the tumor niche, MSC populations can show quiescence, self-renewal capacity, low reactive oxygen species production, and epithelial-to-mesenchymal transition-like properties. These features support acquisition of drug resistance and lead to failure of chemo-radiotherapy.\"},{\"question\":\"How can stemness-related chemoresistance be pharmacologically targeted?\",\"answer\":\"The review examines the mechanisms behind stemness-associated chemoresistance and discusses possibilities for pharmacological targeting. It also highlights new strategies aimed at optimizing chemoradiotherapy and supporting more personalized treatment approaches.\"}]","Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer - Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits | PDF",1790009637,126]